TRANSVAX Trademark

Trademark Overview

On Wednesday, June 13, 2012, a trademark application was filed for TRANSVAX with the United States Patent and Trademark Office. The USPTO has given the TRANSVAX trademark a serial number of 79115813. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, June 13, 2022. This trademark is owned by Astellas Pharma Inc.. The TRANSVAX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
transvax

General Information

Serial Number79115813
Word MarkTRANSVAX
Filing DateWednesday, June 13, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, June 13, 2022
Registration Number4277880
Registration DateTuesday, January 22, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 6, 2012

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Sunday, January 8, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, January 8, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 23, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 3, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 4, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 4, 2020INVALIDATION PROCESSED
Thursday, April 23, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 23, 2019CANCELLED SECTION 71
Friday, July 26, 2013NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 15, 2013CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, July 13, 2013CORRECTION TRANSACTION RECEIVED FROM IB
Friday, May 31, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, April 20, 2013NOTIFICATION PROCESSED BY IB
Saturday, February 23, 2013FINAL DISPOSITION NOTICE SENT TO IB
Saturday, February 23, 2013FINAL DISPOSITION PROCESSED
Thursday, February 21, 2013GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 22, 2013REGISTERED-PRINCIPAL REGISTER
Sunday, November 18, 2012NOTIFICATION PROCESSED BY IB
Tuesday, November 6, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 17, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 17, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 17, 2012NOTICE OF PUBLICATION
Friday, September 28, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 27, 2012ASSIGNED TO EXAMINER
Tuesday, August 21, 2012APPLICATION FILING RECEIPT MAILED
Friday, August 17, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 16, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

transvax human vaccines